These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 21971065)

  • 21. Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addiction.
    Jing L; Li JX
    Eur J Pharmacol; 2015 Aug; 761():345-52. PubMed ID: 26092759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bouncing back: Brain rehabilitation amid opioid and stimulant epidemics.
    Stewart JL; May AC; Paulus MP
    Neuroimage Clin; 2019; 24():102068. PubMed ID: 31795056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurobiology of addictive behaviors and its relationship to methadone maintenance.
    Stimmel B; Kreek MJ
    Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired functional connectivity within and between frontostriatal circuits and its association with compulsive drug use and trait impulsivity in cocaine addiction.
    Hu Y; Salmeron BJ; Gu H; Stein EA; Yang Y
    JAMA Psychiatry; 2015 Jun; 72(6):584-92. PubMed ID: 25853901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
    Chalhoub RM; Kalivas PW
    Drugs; 2020 Oct; 80(15):1509-1524. PubMed ID: 32776315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opiate and cocaine addiction: from bench to clinic and back to the bench.
    Kreek MJ; Zhou Y; Butelman ER; Levran O
    Curr Opin Pharmacol; 2009 Feb; 9(1):74-80. PubMed ID: 19155191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opiates and plasticity.
    Dacher M; Nugent FS
    Neuropharmacology; 2011 Dec; 61(7):1088-96. PubMed ID: 21272593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Neurobehavioral Approach to Addiction: Implications for the Opioid Epidemic and the Psychology of Addiction.
    Bechara A; Berridge KC; Bickel WK; Morón JA; Williams SB; Stein JS
    Psychol Sci Public Interest; 2019 Oct; 20(2):96-127. PubMed ID: 31591935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A neuropeptide-centric view of psychostimulant addiction.
    Boutrel B
    Br J Pharmacol; 2008 May; 154(2):343-57. PubMed ID: 18414383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance use disorders and chronic itch.
    Lipman ZM; Yosipovitch G
    J Am Acad Dermatol; 2021 Jan; 84(1):148-155. PubMed ID: 32891774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal ethanol exposure increases risk of psychostimulant addiction.
    Wang R; Shen YL; Hausknecht KA; Chang L; Haj-Dahmane S; Vezina P; Shen RY
    Behav Brain Res; 2019 Jan; 356():51-61. PubMed ID: 30076855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liking, wanting, and the incentive-sensitization theory of addiction.
    Berridge KC; Robinson TE
    Am Psychol; 2016 Nov; 71(8):670-679. PubMed ID: 27977239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation.
    Schoffelmeer AN; De Vries TJ; Wardeh G; van de Ven HW; Vanderschuren LJ
    J Neurosci; 2002 Apr; 22(8):3269-76. PubMed ID: 11943828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting components of reward: 'liking', 'wanting', and learning.
    Berridge KC; Robinson TE; Aldridge JW
    Curr Opin Pharmacol; 2009 Feb; 9(1):65-73. PubMed ID: 19162544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroscience of opiates for addiction medicine: From stress-responsive systems to behavior.
    Zhou Y; Leri F
    Prog Brain Res; 2016; 223():237-51. PubMed ID: 26806779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine-learning identifies substance-specific behavioral markers for opiate and stimulant dependence.
    Ahn WY; Vassileva J
    Drug Alcohol Depend; 2016 Apr; 161():247-57. PubMed ID: 26905209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation.
    Nader MA; Czoty PW
    Am J Psychiatry; 2005 Aug; 162(8):1473-82. PubMed ID: 16055768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurobiological adaptations to psychostimulants and opiates as a basis of treatment development.
    Sevarino KA; Oliveto A; Kosten TR
    Ann N Y Acad Sci; 2000; 909():51-87. PubMed ID: 10911924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction.
    Blum K; Thanos PK; Oscar-Berman M; Febo M; Baron D; Badgaiyan RD; Gardner E; Demetrovics Z; Fahlke C; Haberstick BC; Dushaj K; Gold MS
    J Reward Defic Syndr; 2015; 1(3):95-104. PubMed ID: 27398406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence.
    Brabant C; Alleva L; Quertemont E; Tirelli E
    Prog Neurobiol; 2010 Nov; 92(3):421-41. PubMed ID: 20638439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.